Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian Ingram

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Neurology|February 9, 2026
MOGAD in South Wales: Diagnostic Evolution and Disease EpidemiologySophie Voase, Patrick Waters, Stephen Jolles, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 17, 2012
Long-term outcome of paediatric-onset multiple sclerosis: a population-based studyKatharine E Harding, Kate Liang, Mark D Cossburn, et al.
Journal of Medical Internet Research|September 23, 2020
A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities TestRod M Middleton, Owen R Pearson, Gillian Ingram, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 2024
Algorithmic approach to finding people with multiple sclerosis using routine healthcare data in WalesRichard Nicholas, Emma Clare Tallantyre, James Witts, et al.
Multiple Sclerosis and Related Disorders|June 3, 2025
Approach to JCV testing with natalizumab biosimilar: a UK consensus statementRuth Dobson, Tarunya Arun, James Varley, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosisEmma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccinationSafiya A Zaloum, Callum H Wood, Pooja Tank, et al.
Annals of Neurology|October 23, 2021
COVID-19 Vaccine Response in People with Multiple SclerosisEmma C Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
European Journal of Human Genetics : EJHG|March 19, 2009
Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factorMaria Ban, An Goris, Aslaug R Lorentzen, et al.
European Journal of Neurology|April 3, 2024
Real-world persistence of multiple sclerosis disease-modifying therapiesEmma C Tallantyre, Ruth Dobson, Joseph L J Froud, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Neurology|February 9, 2026
MOGAD in South Wales: Diagnostic Evolution and Disease EpidemiologySophie Voase, Patrick Waters, Stephen Jolles, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 17, 2012
Long-term outcome of paediatric-onset multiple sclerosis: a population-based studyKatharine E Harding, Kate Liang, Mark D Cossburn, et al.
Journal of Medical Internet Research|September 23, 2020
A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities TestRod M Middleton, Owen R Pearson, Gillian Ingram, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 2024
Algorithmic approach to finding people with multiple sclerosis using routine healthcare data in WalesRichard Nicholas, Emma Clare Tallantyre, James Witts, et al.
Multiple Sclerosis and Related Disorders|June 3, 2025
Approach to JCV testing with natalizumab biosimilar: a UK consensus statementRuth Dobson, Tarunya Arun, James Varley, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosisEmma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccinationSafiya A Zaloum, Callum H Wood, Pooja Tank, et al.
Annals of Neurology|October 23, 2021
COVID-19 Vaccine Response in People with Multiple SclerosisEmma C Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
European Journal of Human Genetics : EJHG|March 19, 2009
Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factorMaria Ban, An Goris, Aslaug R Lorentzen, et al.
European Journal of Neurology|April 3, 2024
Real-world persistence of multiple sclerosis disease-modifying therapiesEmma C Tallantyre, Ruth Dobson, Joseph L J Froud, et al.
Pageof 4